Ivermectin Triple Therapy Protocol for COVID-19 to Australian GP

https://www.bloomberg.com/press-releases/2020-08-19/ivermectin-triple-therapy-protocol-for-covid-19-to-australian-gp

Ivermectin Triple Therapy Protocol for COVID-19 to Australian GP

August 19, 2020, 5:23 PM GMT+10

Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian GPs for
Infected Elderly and Frontline Workers


SYDNEY, Aug 19, 2020 - (ACN Newswire) - Triple therapy specialist Professor
Thomas Borody, famous for curing peptic ulcers using a triple antibiotic
therapy saving millions of lives, today released the COVID-19 treatment
protocol to Australian GPs, who can legally prescribe it to their COVID-19
positive patients, and can also prescribe it as a preventative medication.
Borody says this could be the fastest and safest way to end the pandemic in
Australia within 6-8 weeks.

Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP, FACP, FACG,
AGAF, FRS(N) said:
"The three medications are on chemist shelves right now. GPs can email
GP@CDD.com.au to obtain the dosing protocol and COVID-19 treatment information
for their patients.

"GPs can legally prescribe the therapy today as an "off label"
treatment according to Australian Guidelines - a standard practice in
medicine. In fact more than 60% of prescriptions in Australia are
"off-label". It's not a new concept. It's happening every
day to manage diseases and save lives."

Professor Borody continued:
"We have a therapy that can fight COVID-19. The medications have been
around for 50 years, they are cheap, FDA and TGA approved and have an
outstanding safety profile. Why are we just waiting around for a vaccine? To
save lives we should be using whatever is safe and available right now. We
could lead the world in this fight.

"Australia has some of the best medical and science people in the world -
indeed the Ivermectin connection was first discovered by Dr Kylie
Wagstaff's team at Monash University in April. How long do we need to
wait before Australian politicians get behind Australian medical science and
use 'war room' tactics with safe and approved medications."

Professor Borody, an internationally regarded physician with 4 FDA approved
drugs on the US and Australian markets, is famous for developing the triple
therapy that cured peptic ulcers, saving more than 18,000 lives just in
Australia and millions internationally. [See Professor Borody's published
research at ORCID: http://orcid.org/0000-0002-0519-4698]

"No trial has shown Ivermectin-based therapy to be ineffective. In-fact,
international data reports an almost 100% cure rate and a symptom improvement
within 4-6 days. We should share Australian findings from this triple therapy
with the world," said Professor Borody.

"An Ivermectin tablet can cost as little as $2 - which could make it by
far the cheapest, safest, and fastest cure for Australians and the Australian
economy. This needs to be available for aged care facilities and frontline
health workers today.

"We have written the Federal Health Minister Greg Hunt and Victorian
Premier Daniel Andrews for an urgent medical briefing to bypass the raft of
'advisors' who need to know TGA-approved medicines do not require
animal studies and prolonged clinical trials already done to approve them in
the first place.

"The Government could end the pandemic by openly encouraging GPs to
prescribe these TGA approved medications. Those who test positive, are
identified in contact tracing, as well as those in high-risk groups like the
elderly and healthcare workers, can then access the therapy quickly,"
said Professor Borody.

Ivermectin was discovered in the 1970s and is on the World Health Organization
(WHO) list of essential medicines.
"There is mounting worldwide clinical literature pointing to a 100% cure
rate using Ivermectin Triple Therapy," he said.

There are currently 28 COVID-19 Ivermectin treatment studies running globally.
Research papers include:

WHO:
Mass treatment with ivermectin: an underutilized public health strategy
https://www.who.int/bulletin/volumes/82/8/editorial30804html/en/

ResearchSquare:
A Randomized Trial of Ivermectin-Doxycycline and
Hydroxychloroquine-Azithromycin therapy on COVID19 patients
https://www.researchsquare.com/article/rs-38896/v1

MedRxiv:
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot
Trial)
https://www.medrxiv.org/content/10.1101/2020.07.07.20145979v1

Journal of Antibiotics:
Ivermectin: a systematic review from antiviral effects to COVID-19
complementary regimen
https://www.nature.com/articles/s41429-020-0336-z

ResearchGate:
A Case Series of 100 COVID-19 Positive Patients Treated with Combination of
Ivermectin and Doxycycline
https://www.researchgate.net/publication/343305357

ermectin_and_Doxycycline

Journal of Bangladesh College of Physicians and Surgeons:
A Case Series of 100 COVID-19 Positive Patients Treated with Combination of
Ivermectin and Doxycycline
https://www.banglajol.info/index.php/JBCPS/article/view/47512

Journal of Bangladesh College of Physicians and Surgeons:
Comparison of Viral Clearance between Ivermectin with Doxycycline and
Hydroxychloroquine with Azithromycin in COVID-19 Patients
https://www.banglajol.info/index.php/JBCPS/article/view/47514

MedRxiv:
ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated
with Lower Mortality in Hospitalized Patients with COVID19
https://www.medrxiv.org/content/10.1101/2020.06.06.20124461v2

ChemRxiv:
Has Ivermectin Virus-Directed Effects against SARS-CoV-2? Rationalizing the
Action of a Potential Multitarget Antiviral Agent
https://chemrxiv.org/articles/preprint/12782258

on_of_a_Potential_Multitarget_Antiviral_Agent/12782258

Professor Borody says his research has led him to a triple therapy of
Ivermectin, zinc and an antibiotic - which are all TGA and FDA approved. The
therapy comprises:

1. Ivermectin - TGA and FDA approved as an anti-parasitic therapy with an
established safety profile since the 1970s. Known as the "Wonder
Drug" from Japan.
2. Zinc
3. Doxycycline - TGA and FDA approved tetracycline antibiotic that fights
bacterial infections, eg. acne or urinary tract infections, viral and malarial
infections.

Professor Borody is involved in a Phase 2 study in the US to potentially
develop the triple therapy as a single "blister pack" compliance
product. He says, "Our study in the US is looking at developing the
triple therapy as a single product which requires FDA approval, even though
all 3 medications separately are already approved." [US clinical trial:
https://clinicaltrials.gov/ct2/show/NCT04482686?term=Ivermectin+borody]

About the Centre for Digestive Diseases (CDD)

The Sydney-based Centre for Digestive Diseases (CDD) provides patients with
innovative therapies not available in the rest of the world. The Hospital
features cutting-edge technologies enabling our specialists to provide
world-class treatments. Visit https://centrefordigestivediseases.com.

Professor Borody is best known internationally for his work in gut and its
mircobiome infections and re-purposing antimicrobial drugs for new diseases
including the triple therapy cure for peptic ulcers. His discoveries prevented
premature deaths in over 18,000 people and saved the Federal Government a
reported $10 billion. [THEMA Report]

Professor Borody developed a triple therapy for the treatment for Crohn's
Disease, and has developed 4 FDA approved pharmaceuticals for the USA and
international markets.

For interviews please contact:
Kate Newton, Digital Mantra Group
E: team@DMGPR.com; AU: +61 2 8218 2144
US: +1 415 951 3228; ASIA: +65 3159 3427



Centre for Digestive Diseases (CDD)



Copyright 2020 ACN Newswire . All rights reserved.